United Therapeutics Corporation (UTHR) Upgraded to "Buy" at ValuEngine
A number of other analysts also recently issued reports on UTHR. Oppenheimer Holdings, Inc. reaffirmed a buy rating on shares of United Therapeutics Corporation in a research note on Friday, September 8th.
from Biotech News
0 Comments